This new 282-page report from Venture Planning Group presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.... Research Beam Model: Research Beam Product ID: 15073 1500 USD New
2014 Opportunities in the Japanese Respiratory Diseases Diagnostic Testing Market

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

2014 Opportunities in the Japanese Respiratory Diseases Diagnostic Testing Market

 
 
 

About This Report



This new 282-page report from Venture Planning Group presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.    



In addition to market share and sales forecasts, the report:



-  Examines market applications of Molecular Diagnostics,   Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;



-  Reviews features and operating characteristics of major analyzers used for microbiology testing;



-  Profiles key suppliers and potential market entrants developing innovative   technologies and products; and



-  Analyzes emerging opportunities, alternative market penetration strategies,  market entry barriers/risks, and strategic planning issues.



 



Methodology



The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.



In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group’s proprietary data files was conducted.



 

Contains 282  pages and 22  tables